It’s a big year in the world of Alzheimer’s research. In early July, the FDA approved the Alzheimer’s drug Leqembi, which is the first drug to show clinical evidence of slowing down cognitive decline.

The first-ever blood test to detect Alzheimer’s disease has been cleared by the U.S. Food and Drug Administration (FDA). In a Friday press release, the agency announced its approval of the first ...

Panelists discuss how earlier Alzheimer diagnosis enhances treatment planning and slows disease progression. Panelists ...

A work group convened by the Alzheimer's Association has released revised biology-based criteria for the diagnosis and staging of Alzheimer's disease (AD), including a new biomarker classification ...

The way doctors diagnose Alzheimer’s disease soon could change. A proposal updating existing diagnostic criteria, which was introduced at the Alzheimer’s Association International Conference in ...

Department Of Morphological And Functional Imaging, at The Pitie Salpetriere Hospital In Paris, France. On The Left, Normal Brain. On The Right, Probable Alzheimer's Disease. (Photo By BSIP/UIG Via ...

Alzheimer’s disease is diagnosed with multiple types of tests that also help to rule out other possible conditions with similar symptoms. You may have blood and urine tests, memory function tests, and ...

Many Alzheimer’s experts were dismayed — but not surprised — when the Alzheimer’s Association stated that the disease could be diagnosed on the basis of pathology using biomarkers, rather than ...

With the administration change in Washington, questions abound regarding the impact of new healthcare appointees across healthcare agencies. While it will take time to enact any presumed or planned ...

The latest effort to rewrite the diagnostic criteria for Alzheimer’s disease has stirred more than a little controversy. While the proposed revisions have garnered praise from researchers for more ...

Amyloid plaque, a feature of Alzheimer's disease, accumulates outside neurons. A new blood test, Lumipulse, measures two subtypes of tau and amyloid proteins, of which certain levels can predict the ...

PHILADELPHIA -- A blood test performed better than a standard evaluation by primary care doctors or dementia specialists in detecting Alzheimer's disease among people with cognitive symptoms. The ...